178 related articles for article (PubMed ID: 11685490)
1. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
[TBL] [Abstract][Full Text] [Related]
2. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
3. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
King SC; Reiman RJ; Prosnitz LR
J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease. Prognostic value of Gallium-67 scintigraphy.
Hervás I; Segura A; López-Tendero P; Bello P; González-Cabezas P; Flores D; Yuste A; Pérez-Velasco R; Girones R; Mateo A
Q J Nucl Med; 2003 Jun; 47(2):101-8. PubMed ID: 12865870
[TBL] [Abstract][Full Text] [Related]
6. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
[TBL] [Abstract][Full Text] [Related]
7. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
9. Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
Re A; Ferrari S; Frata P; Pizzocaro C; Crippa C; Tucci A; Facchetti F; Grazioli L; Magrini SM; Rossi G
Ann Oncol; 2008 May; 19(5):951-7. PubMed ID: 18209012
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 1999 Feb; 210(2):487-91. PubMed ID: 10207434
[TBL] [Abstract][Full Text] [Related]
12. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
[TBL] [Abstract][Full Text] [Related]
13. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
14. Negative gallium-67 citrate and positive positron emission tomography/computed tomography spleen scans, in Hodgkin's stage IV lymphoma.
Malamitsi J; Kosmidis H; Valotassiou B; Bonou I; Andreou J
Hell J Nucl Med; 2007; 10(2):116-8. PubMed ID: 17684589
[TBL] [Abstract][Full Text] [Related]
15. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
16. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
17. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.
Gallamini A; Hutchings M; Rigacci L; Specht L; Merli F; Hansen M; Patti C; Loft A; Di Raimondo F; D'Amore F; Biggi A; Vitolo U; Stelitano C; Sancetta R; Trentin L; Luminari S; Iannitto E; Viviani S; Pierri I; Levis A
J Clin Oncol; 2007 Aug; 25(24):3746-52. PubMed ID: 17646666
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement.
Zinzani PL; Magagnoli M; Franchi R; Zompatori M; Frezza G; Galassi R; Gherlinzoni F; Bendandi M; Albertini P; Monetti N; Tura S
Haematologica; 1999 Jul; 84(7):604-7. PubMed ID: 10406901
[TBL] [Abstract][Full Text] [Related]
19. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
Liu FY; Shiau YC; Yen RF; Wang JJ; Ho ST; Kao CH
Ann Nucl Med; 2003 Sep; 17(6):439-42. PubMed ID: 14575376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
